Opioids Market - Size, Share & Forecast till
2025
Opioid drugs bind to opioid receptors that are present in several areas of the nervous system
such as the brain and spinal cord. Medically, they are primarily being used for pain relief. The
drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic
opioids. However, its application is not limited to pain relief alone and has been successfully
used for treatment of various other medical conditions such as diarrhea and cough. Opioid
drugs can be broadly divided into two categories, mild and major opioids, on the basis of its
efficacy. Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Overdose and drug abuse is a major concern, with the situation alarming in developed regions.
According to World Drug Report 2017, 29.5 million people suffered from drug use disorders in
2015 and staggering 70% of this 29.5 million were attributed to opioids only.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/1017
Market Dynamics
Incidence of chronic pain, which is primarily treated by opioids has witnessed continuous
growth over the last decades. According to a report titled Pain in Europe, published in 2006,
chronic pain affected around one in five (19%) adults, and prevalence was recorded to be the
highest in Norway, Poland, and Italy, where one-fourth of adults were suffering from chronic
pain. According to a study titled Prevalence of Chronic Pain in the UK, published in The BMJ
(British Medical Journal), in 2013, chronic pain affects between one-third and one-half of the
population in the U.K, indicating high prevalence rate. Prevalence rate is similar in other
developed countries such as the U.S. Rapidly increasing incidence of chronic pain is thus
expected to boost growth of the opioids market over the forecast period.
However, increasing usage of opioids, has led to increase in its overuse or abuse over the
recent past. To tackle this situation, CDC published guidelines for prescribing opioids for
chronic pain. Similar efforts to curtail opioid overuse are underway in developed economies of
Europe. Such intervention by regulatory bodies are expected to obstruct growth of the opioids
market.